Indeed, silencing of NOTCH3 in two bladder cancer cell lines sensitised one cell line to cisplatin, which is known to inhibit the SERCA pump, just like the recently discovered CAD204520 that can block oncogenic NOTCH [93,113]. This evidence concerns the gene NOTCH3 and urinary bladder carcinoma.